Wednesday, July 8, 2026

pharma · Acute Myeloid Leukemia · Breast Cancer

First People's Hospital

First People's Hospital is a pharma organization headquartered in SAN DIEGO, CA, CN. Primary therapeutic focus areas include Acute Myeloid Leukemia, Breast Cancer, Gastric Cancer, Multiple Myeloma, Esophageal Squamous Ce

SAN DIEGO, CA, CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
SAN DIEGO, CA, CN
Programs
1136
Drugs
626
Patents
123
Clinical program

Regorafenib and Sintilimab in combination with electroacupuncture

Unknown · small molecule · Colorectal Cancer Metastatic

Regorafenib and Sintilimab in combination with electroacupuncture for Colorectal Cancer Metastatic is a Unknown program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Internal code F-IRB-SOP-00710

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
The First People's Hospital of Lianyungang
Phase
Unknown
Modality
small_molecule
Indication
Colorectal Cancer Metastatic
Status
active
Trials
1